First Pacific Advisors’s Pfizer PFE Stock Holding History

First Pacific Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-13,702	Closed	-$471K	–	134
2017 Q4	$471K	Buy	+13,702	New	+$467K	﹤0.01%	121

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

First Pacific Advisors's PFE Position: Q1 2018 in Review

First Pacific Advisors sold out of Pfizer (PFE) in Q1 2018, closing a stake of 13,702 shares — an estimated $471K sold.

First Pacific Advisors first reported a position in PFE in Q4 2017 and held it in 1 quarter. The position peaked at $471K in Q4 2017. 2,229 funds tracked by Wall St. Rank hold PFE as of Q1 2018.

First Pacific Advisors reported no remaining Pfizer position as of Q1 2018 after selling out during the quarter.
First Pacific Advisors sold 13,702 Pfizer shares in Q1 2018, an estimated $471K.
First Pacific Advisors first reported a position in Pfizer in Q4 2017 and held it in 1 quarter.
First Pacific Advisors's Pfizer position peaked at $471K in Q4 2017.
2,229 funds tracked by Wall St. Rank held Pfizer as of Q1 2018.

Based on First Pacific Advisors's 13F filing for Q1 2018, filed 14 May 2018.